CS Analytical Laboratory, the world’s only FDA regulated contract laboratory exclusively dedicated to providing regulatory solutions and qualification testing services specifically for drug product and medical device container systems, is excited to announce a variety of notable achievements that have taken place over the first half of 2023.

“To remain relevant and deliver value to the marketplace, we must continue to develop programs and services that enable clients to meet the ever-changing and often complicated regulatory requirements for their container and package systems. The CS Analytical Team is committed to this endeavor by making it our mission to share our experience, knowledge and commitment to regulatory compliance with each client and bring an “exceeds expectations” level of service to each test program,” noted CEO Brian Mulhall.

The CS Analytical Team offers comprehensive CCI method development, validation, and analysis, as well as USP/EP/JP physical performance tests and physicochemical tests for all common or unique primary packaging components and systems. In addition, CS Analytical offers a host of support and complimentary testing programs that ensure all aspects of the regulatory requirements are met for any type of container system. Whether a unique product storage device or a challenging and oversize IV bag system, the CS Analytical Team has the knowledge and hands-on experience to develop a qualification test program that ensures all regulatory compliance factors are met.